Average Co-Inventor Count = 3.22
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Idun Pharmaceuticals, Inc. (8 from 33 patents)
2. Other (1 from 832,680 patents)
3. Bristol-myers Squibb Pharma Company (1 from 234 patents)
10 patents:
1. 6825208 - Tetrahydroquinoline derivatives as antithrombotic agents
2. 6693096 - Treatment of inflammation-associated disorders using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors
3. 6610683 - Treatment of infectious disease using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors
4. 6531467 - Inhibition of inflammation using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors
5. 6528506 - Inhibition of apoptosis using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors
6. 6489353 - C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
7. 6200969 - Inhibition of apoptosis using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors
8. 6184244 - C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
9. 5877197 - C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors
10. 5869519 - C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors